about
Recent advances in antimultiple myeloma drug development.Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapiesA phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma.Antibody-based therapies in multiple myelomaDesign, synthesis and biological characterization of novel inhibitors of CD38.CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.Immuno-targeting the multifunctional CD38 using nanobodyFrom the bench to the bedside: emerging new treatments in multiple myeloma.T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1.CD38 and CD157: biological observations to clinical therapeutic targets.Preclinical Development of CD38-Targeted [89Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.1,2,3,4,6-Penta-O-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC Expression.
P2860
Q33416297-018ED880-C0ED-4A35-BAEA-2DBE164F0415Q33730375-CA6C5878-95EA-4EE6-AE01-8A4FBAB53EF2Q34634446-9F1000E7-FE9B-4593-9A26-5830BFC199F7Q35431150-23DCD249-4155-43B5-8125-70465EAE40CCQ35977067-F31B249F-E30E-4633-B685-A5D501BA90A5Q36118086-46FA377E-EF22-4D91-A11B-90D1C3C8164FQ36959363-BC41A1D0-898D-4FDC-BC46-D46B04910E0EQ37028598-997E3191-47CE-459E-A3E6-4FE9A149ED39Q42195075-220E6B68-AC80-4782-9731-0E7E2F32AABAQ42912215-E30E82FE-BA0C-4A1A-9D88-AD907695E2C0Q50061670-464B4184-331B-4946-B2B4-EA371F50AF09Q50199534-B2CE10F4-3573-4275-AE73-890E72D7AE1E
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
CD38 as a therapeutic target.
@ast
CD38 as a therapeutic target.
@en
CD38 as a therapeutic target.
@nl
type
label
CD38 as a therapeutic target.
@ast
CD38 as a therapeutic target.
@en
CD38 as a therapeutic target.
@nl
prefLabel
CD38 as a therapeutic target.
@ast
CD38 as a therapeutic target.
@en
CD38 as a therapeutic target.
@nl
P2860
P1433
P1476
CD38 as a therapeutic target.
@en
P2093
George T Stevenson
P2860
P304
P356
10.2119/2006–00082.STEVENSON
P407
P577
2006-11-01T00:00:00Z